Mostrar el registro sencillo del ítem
dc.contributor.author
Nayyar, Gaurvika M. L.
dc.contributor.author
Attaran, Amir
dc.contributor.author
Clark, John P.
dc.contributor.author
Culzoni, Maria Julia
![Se ha confirmado la validez de este valor de autoridad por un usuario](/themes/CONICETDigital/images/authority_control/invisible.gif)
dc.contributor.author
Fernandez, Facundo M.
dc.contributor.author
Herrington, James E.
dc.contributor.author
Kendall, Megan
dc.contributor.author
Newton, Paul N.
dc.contributor.author
Breman, Joel G.
dc.date.available
2018-05-28T21:45:24Z
dc.date.issued
2015-06
dc.identifier.citation
Nayyar, Gaurvika M. L.; Attaran, Amir; Clark, John P.; Culzoni, Maria Julia; Fernandez, Facundo M.; et al.; Responding to the Pandemic of Falsified Medicines; American Society of Tropical Medicine and Hygiene; American Journal of Tropical Medicine and Hygiene; 92; suppl 6; 6-2015; 113-118
dc.identifier.issn
0002-9637
dc.identifier.uri
http://hdl.handle.net/11336/46371
dc.description.abstract
Over the past decade, the number of countries reporting falsified (fake, spurious/falsely labeled/counterfeit) medicines and the types and quantities of fraudulent drugs being distributed have increased greatly. The obstacles in combating falsified pharmaceuticals include 1) lack of consensus on definitions, 2) paucity of reliable and scalable technology to detect fakes before they reach patients, 3) poor global and national leadership and accountability systems for combating this scourge, and 4) deficient manufacturing and regulatory challenges, especially in China and India where fake products often originate. The major needs to improve the quality of the world?s medicines fall into three main areas: 1) research to develop and compare accurate and affordable tools to identify high-quality drugs at all levels of distribution; 2) an international convention and national legislation to facilitate production and utilization of high-quality drugs and protect all countries from the criminal and the negligent who make, distribute, and sell life-threatening products; and 3) a highly qualified, well-supported international science and public health organization that will establish standards, drug-quality surveillance, and training programs like the U.S. Food and Drug Administration. Such leadership would give authoritative guidance for countries in cooperation with national medical regulatory agencies, pharmaceutical companies, and international agencies, all of which have an urgent interest and investment in ensuring that patients throughout the world have access to good quality medicines. The organization would also advocate strongly for including targets for achieving good quality medicines in the United Nations Millennium Development Goals and Sustainable Development Goals.
dc.format
application/pdf
dc.language.iso
eng
dc.publisher
American Society of Tropical Medicine and Hygiene
dc.rights
info:eu-repo/semantics/openAccess
dc.rights.uri
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
dc.subject
Falsified Medicines
dc.subject
Pandemic
dc.subject
Laboratory And Field Innovations
dc.subject
Policy Perspectives
dc.subject.classification
Salud Ocupacional
![Se ha confirmado la validez de este valor de autoridad por un usuario](/themes/CONICETDigital/images/authority_control/invisible.gif)
dc.subject.classification
Ciencias de la Salud
![Se ha confirmado la validez de este valor de autoridad por un usuario](/themes/CONICETDigital/images/authority_control/invisible.gif)
dc.subject.classification
CIENCIAS MÉDICAS Y DE LA SALUD
![Se ha confirmado la validez de este valor de autoridad por un usuario](/themes/CONICETDigital/images/authority_control/invisible.gif)
dc.title
Responding to the Pandemic of Falsified Medicines
dc.type
info:eu-repo/semantics/article
dc.type
info:ar-repo/semantics/artículo
dc.type
info:eu-repo/semantics/publishedVersion
dc.date.updated
2018-04-27T20:27:01Z
dc.journal.volume
92
dc.journal.number
suppl 6
dc.journal.pagination
113-118
dc.journal.pais
Estados Unidos
![Se ha confirmado la validez de este valor de autoridad por un usuario](/themes/CONICETDigital/images/authority_control/invisible.gif)
dc.journal.ciudad
Stanford
dc.description.fil
Fil: Nayyar, Gaurvika M. L.. University Johns Hopkins; Estados Unidos
dc.description.fil
Fil: Attaran, Amir. University of Otawa; Canadá
dc.description.fil
Fil: Clark, John P.. Pfizer Pharmaceuticals; Estados Unidos
dc.description.fil
Fil: Culzoni, Maria Julia. Universidad Nacional del Litoral. Facultad de Bioquímica y Ciencias Biológicas; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Santa Fe; Argentina
dc.description.fil
Fil: Fernandez, Facundo M.. University of North Carolina; Estados Unidos
dc.description.fil
Fil: Herrington, James E.. University of Otawa; Canadá
dc.description.fil
Fil: Kendall, Megan. Lao-Oxford-Mahosot Hospital; Reino Unido
dc.description.fil
Fil: Newton, Paul N.. University of Oxford; Reino Unido
dc.description.fil
Fil: Breman, Joel G.. National Institutes of Health; Estados Unidos
dc.journal.title
American Journal of Tropical Medicine and Hygiene
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/doi/https://doi.org/10.4269/ajtmh.14-0393
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/url/http://www.ajtmh.org/content/journals/10.4269/ajtmh.14-0393
Archivos asociados